tiagabine trade name gabitril anticonvulsant medication produced cephalon used treatment epilepsy drug also used offlabel treatment anxiety disorders panic disorder tiagabine approved us food drug administration fda adjunctive treatment partial seizures individuals age may also prescribed offlabel physicians treat anxiety disorders panic disorder well neuropathic pain including fibromyalgia anxiety neuropathic pain tiagabine used primarily augment treatments tiagabine may used alongside selective serotonin reuptake inhibitors serotoninnorepinephrine reuptake inhibitors benzodiazepines anxiety antidepressants gabapentin anticonvulsants opioids neuropathic effective monotherapy combination therapy antiepileptic drugs treatment partial american academy sleep medicines clinical practice guidelines recommended use tiagabine treatment insomnia due poor effectiveness low quality side effects tiagabine dose common side effect tiagabine side effects observed rate statistical significance relative placebo include asthenia somnolence nervousness memory impairment tremor headache diarrhea adverse effects confusion aphasia difficulty speaking clearlystuttering paresthesia tingling sensation bodys extremities particularly hands fingers may occur higher dosages drug eg tiagabine may induce seizures without epilepsy particularly taking another drug lowers seizure may increased risk psychosis tiagabine treatment although data mixed tiagabine also reportedly interfere visual color tiagabine overdose produce neurological symptoms lethargy single multiple seizures status epilepticus coma confusion agitation tremors dizziness dystoniasabnormal posturing hallucinations well respiratory depression tachycardia hypertension overdose may fatal especially victim presents severe respiratory depression andor tiagabine increases level Î³aminobutyric acid gaba major inhibitory neurotransmitter central nervous system blocking gaba transporter hence classified gaba reuptake inhibitor tiagabine primarily used anticonvulsant treatment epilepsy supplement although exact mechanism tiagabine exerts antiseizure effect unknown thought related ability increase activity gamma aminobutyric acid gaba central nervous systems major inhibitory neurotransmitter tiagabine attaches gaba uptake carriers recognition sites tiagabine thought block gaba uptake presynaptic neurons result action allowing gaba available receptor binding surfaces postsynaptic tiagabine enhances power cortical delta hz oscillations relative placebo may result eeg meg signature resembling nonrapid eye movement sleep even person taken tiagabine awake demonstrates cortical delta activity wakeful consciousness mutually exclusive ie high amplitude delta oscillations always reliable indicator unconsciousness seizure frequency liver function tests tiagabine discovered novo nordisk denmark team medicinal chemists pharmacologists general direction claus drug codeveloped abbott laboratories cost sharing deal abbott paying premium licensing ip danish companycitation needed us patents tiagabine listed orange book expired april httpsenwikipediaorgwikitiagabine